197 related articles for article (PubMed ID: 12561042)
1. Topical rose bengal: pre-clinical evaluation of pharmacokinetics and safety.
Wachter E; Dees C; Harkins J; Scott T; Petersen M; Rush RE; Cada A
Lasers Surg Med; 2003; 32(2):101-10. PubMed ID: 12561042
[TBL] [Abstract][Full Text] [Related]
2. Phototoxicity is not associated with photochemical tissue bonding of skin.
Yao M; Yaroslavsky A; Henry FP; Redmond RW; Kochevar IE
Lasers Surg Med; 2010 Feb; 42(2):123-31. PubMed ID: 20166159
[TBL] [Abstract][Full Text] [Related]
3. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
Boiy A; Roelandts R; van den Oord J; de Witte PA
Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
[TBL] [Abstract][Full Text] [Related]
4. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial effect of photodynamic therapy using high-power blue light-emitting diode and red-dye agent on Porphyromonas gingivalis.
Chui C; Aoki A; Takeuchi Y; Sasaki Y; Hiratsuka K; Abiko Y; Izumi Y
J Periodontal Res; 2013 Dec; 48(6):696-705. PubMed ID: 23441868
[TBL] [Abstract][Full Text] [Related]
6. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
Bissonnette R; Sharfaei S; Viau G; Liu Y
Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation.
Sugita N; Kawabata K; Sasaki K; Sakata I; Umemura S
Bioconjug Chem; 2007; 18(3):866-73. PubMed ID: 17367181
[TBL] [Abstract][Full Text] [Related]
8. Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells.
Theodossiou T; Hothersall JS; Woods EA; Okkenhaug K; Jacobson J; MacRobert AJ
Cancer Res; 2003 Apr; 63(8):1818-21. PubMed ID: 12702568
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
[TBL] [Abstract][Full Text] [Related]
10. Topical photodynamic therapy for dermatologic disorders: results and complications.
Redbord KP; Hanke CW
J Drugs Dermatol; 2007 Dec; 6(12):1197-202. PubMed ID: 18189059
[TBL] [Abstract][Full Text] [Related]
11. Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal.
Ali MF
Lasers Med Sci; 2011 Mar; 26(2):267-75. PubMed ID: 21120567
[TBL] [Abstract][Full Text] [Related]
12. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N
Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441
[TBL] [Abstract][Full Text] [Related]
13. Topical liposomal Rose Bengal for photodynamic white hair removal: randomized, controlled, double-blind study.
Samy N; Fadel M
J Drugs Dermatol; 2014 Apr; 13(4):436-42. PubMed ID: 24719063
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
16. Improving Dermal Delivery of Rose Bengal by Deformable Lipid Nanovesicles for Topical Treatment of Melanoma.
Demartis S; Rassu G; Murgia S; Casula L; Giunchedi P; Gavini E
Mol Pharm; 2021 Nov; 18(11):4046-4057. PubMed ID: 34554752
[TBL] [Abstract][Full Text] [Related]
17. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular assessment of rose bengal photodynamic antimicrobial therapy on keratocytes, corneal endothelium and limbal stem cell niche.
Naranjo A; Pelaez D; Arrieta E; Salero-Coca E; Martinez JD; Sabater AL; Amescua G; Parel JM
Exp Eye Res; 2019 Nov; 188():107808. PubMed ID: 31539544
[TBL] [Abstract][Full Text] [Related]
19. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
20. An in vitro study of the photodynamic effect of rose bengal on Trichophyton rubrum.
Cronin L; Moffitt M; Mawad D; Morton OC; Lauto A; Stack C
J Biophotonics; 2014 Jun; 7(6):410-7. PubMed ID: 23125143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
